
Click here to view video.
Enter Dysport: Here Come the Botox Competitors
Next month, Dr. Hamori will speak about Dysport, from Medicis (an up and coming Botox competitor) and its family of injectables (Restylane/Perlane) with other physicians during the American Association of Dermatologists meeting in Boston. Dr. Hamori expects to have the new product in the office to inject very soon.
Here is a link to yesterday's news release on Dysport (formerly known as Reloxin) becoming available in the U.S.: Medicis Begins Shipping Dysport(TM) for Glabellar Lines.
And here is the WebMD report on Dysport's FDA approval.
Stay tuned for more news on Dysport.